US · Healthcare · Biotechnology
EPS came in at -0.12 against a street estimate of -0.15 — a beat of 20.0%.
Analysts rate Fractyl Health, Inc. Common Stock a strong buy (6 buy, 0 hold, 0 sell out of 6) with an average price target of $23.60.
| Fund | Stake |
|---|---|
| Nantahala Capital Management, LLC | 14.18% |
| Catalio Capital Management, LP | 3.88% |
| Vanguard Capital Management, LLC | 3.83% |
| Bank of America Corp | 3.79% |
| Pale Fire Capital SE | 3.14% |
| General Catalyst Group Management, LLC | 3.07% |
| Deer Management Co. LLC | 3.00% |
| Maverick Capital Ltd | 2.50% |
| Action | Detail | Date |
|---|---|---|
| Split | 1 : 12 effective Oct 5, 2026 | 2026-10-05 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Fractyl Health, Inc. Common Stock — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-11-07.